Safety and Preliminary Efficacy of TSHA-102 Gene Therapy in Pediatric Females Aged >2 to <4 Years With Rett Syndrome
Abroad (travel likely)RecruitingPHASE3
Conditions
Rett Syndrome
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Boston Children's Hospital, Boston, Massachusetts, United States
Study leads
Medical Monitor, M.D.
Study Director
Taysha Gene Therapies